A retrospective cohort study revealed that nicotinamide exposure among adults did not increase the risk for major adverse cardiovascular events.
Some patients with atopic dermatitis who qualify for advanced systemic therapies do not receive them or may lack improvement with these therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback